CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 166 filers reported holding CASTLE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,016,797 | +21.1% | 2,487,673 | -1.7% | 1.50% | +40.2% |
Q2 2023 | $34,703,793 | +27.3% | 2,529,431 | +110.8% | 1.07% | +28.7% |
Q1 2023 | $27,265,113 | +10.9% | 1,200,049 | +14.9% | 0.83% | +10.4% |
Q4 2022 | $24,583,481 | +23.7% | 1,044,328 | +37.0% | 0.75% | +15.9% |
Q3 2022 | $19,879,000 | -0.1% | 762,217 | -15.9% | 0.65% | -4.6% |
Q2 2022 | $19,903,000 | -44.1% | 906,764 | +14.2% | 0.68% | -23.1% |
Q1 2022 | $35,606,000 | +12.6% | 793,715 | +7.6% | 0.88% | +35.8% |
Q4 2021 | $31,611,000 | +5.4% | 737,374 | +63.5% | 0.65% | +14.4% |
Q3 2021 | $29,990,000 | -8.0% | 450,980 | +1.4% | 0.57% | -6.3% |
Q2 2021 | $32,605,000 | +67.6% | 444,629 | +56.4% | 0.61% | +47.0% |
Q1 2021 | $19,458,000 | +27.7% | 284,221 | +25.2% | 0.41% | +20.8% |
Q4 2020 | $15,242,000 | -19.5% | 226,988 | -38.3% | 0.34% | -46.7% |
Q3 2020 | $18,928,000 | +82.2% | 367,885 | +33.5% | 0.64% | +70.7% |
Q2 2020 | $10,388,000 | +755.7% | 275,630 | +576.7% | 0.38% | +478.5% |
Q1 2020 | $1,214,000 | -33.2% | 40,730 | -23.0% | 0.06% | -22.6% |
Q4 2019 | $1,817,000 | – | 52,863 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |